These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 25262963)

  • 1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
    Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of novel intrinsic versus conventional antitachycardia pacing for ventricular tachycardia among implantable cardioverter-defibrillator recipients.
    Yanagisawa S; Inden Y; Sato Y; Watanabe R; Goto T; Kondo S; Tachi M; Iwawaki T; Yamauchi R; Hiramatsu K; Shimojo M; Tsuji Y; Shibata R; Murohara T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):821-831. PubMed ID: 38424678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of anti-tachycardia pacing efficacy through scar-specific delivery and minimization of re-initiation: a virtual study on a cohort of infarcted porcine hearts.
    Qian S; Connolly A; Mendonca-Costa C; Campos F; Rodero C; Whitaker J; Rinaldi CA; Bishop MJ
    Europace; 2023 Feb; 25(2):716-725. PubMed ID: 36197749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-silico assessment of efficacy of two novel intra-cardiac electrode configurations versus traditional anti-tachycardia pacing therapy for terminating sustained ventricular tachycardia.
    Qian S; Connolly A; Mendonca-Costa C; Campos F; Williams SE; Whitaker J; Rinaldi CA; Bishop MJ
    Comput Biol Med; 2021 Dec; 139():104987. PubMed ID: 34741904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy.
    Tsukahara K; Oginosawa Y; Fujino Y; Honda T; Kikuchi K; Nozoe M; Uchida T; Minamiguchi H; Sonoda K; Ogawa M; Ideguchi T; Kizaki Y; Nakamura T; Oba K; Higa S; Yoshida K; Yagyu K; Miyamoto T; Yamagishi Y; Ohe H; Kohno R; Kataoka M; Otsuji Y; Abe H
    J Arrhythm; 2021 Aug; 37(4):1052-1060. PubMed ID: 34386132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes.
    Fang Y; Gu K; Yang B; Ju W; Chen H; Li M; Liu H; Wang J; Yang G; Chen M
    J Arrhythm; 2018 Feb; 34(1):36-45. PubMed ID: 29721112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-derived cycle length variability metrics predict spontaneously terminating ventricular tachycardia in implantable cardioverter defibrillator recipients.
    Sau A; Ahmed A; Chen JY; Pastika L; Wright I; Li X; Handa B; Qureshi N; Koa-Wing M; Keene D; Malcolme-Lawes L; Varnava A; Linton NWF; Lim PB; Lefroy D; Kanagaratnam P; Peters NS; Whinnett Z; Ng FS
    Eur Heart J Digit Health; 2024 Jan; 5(1):50-59. PubMed ID: 38264702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project.
    Schiavone M; Gasperetti A; Compagnucci P; Vogler J; Laredo M; Montemerlo E; Gulletta S; Breitenstein A; Ziacchi M; Martinek M; Casella M; Palmisano P; Kaiser L; Lavalle C; Calò L; Seidl S; Saguner AM; Rovaris G; Kuschyk J; Biffi M; Di Biase L; Dello Russo A; Tondo C; Della Bella P; Tilz R; Forleo GB;
    Europace; 2024 Mar; 26(4):. PubMed ID: 38584394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator.
    Awad SS; Azeez EF; Taha MO; El-Naggar WM; El-Damaty A
    Egypt Heart J; 2023 Jun; 75(1):44. PubMed ID: 37266828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study.
    Chinushi M; Saitoh O; Furushima H; Aizawa Y; Noda T; Nitta T; Ohe T; Kurita T
    J Arrhythm; 2021 Aug; 37(4):1038-1045. PubMed ID: 34386130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considering the Need to Expand the Indications for Wearable Defibrillator Therapy.
    J Innov Card Rhythm Manag; 2019 Jul; 10(7):3751-3760. PubMed ID: 32494421
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic Microparticles.
    Rotenberg MY; Gabay H; Etzion Y; Cohen S
    Sci Rep; 2016 Apr; 6():24635. PubMed ID: 27091192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients. Primary results of the SATISFACTION study.
    Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Okuyama Y; Mizuno H; Shimoshige S; Takenaka S; Sumiyoshi T; Yambe Y; Shirota K; Nitta J; Ito M; Keida T; Nanto S
    Circ J; 2014; 78(11):2643-50. PubMed ID: 25262963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
    Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
    Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pace-terminated ventricular arrhythmias.
    Pokorney SD; Al-Khatib SM
    Card Electrophysiol Clin; 2015 Sep; 7(3):497-513. PubMed ID: 26304530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial.
    Lunati M; Defaye P; Mermi J; Garcia-Alberola A; Merino JL; Arenal A; Cappato R; Navarro X; Passardi M; Santini M
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S35-9. PubMed ID: 17169131
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.